Multicentre randomised controlled trial comparing uterine artery embolisation with surgical treatment for uterine fibroids

ISRCTN ISRCTN23023665
DOI https://doi.org/10.1186/ISRCTN23023665
Secondary identifying numbers czh/4/1
Submission date
08/03/2006
Registration date
16/03/2006
Last edited
04/02/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Uterine fibroids are non-cancerous growths that form on the wall of a woman's womb (uterus). Several different procedures can be used to treat fibroids. Surgical treatments include myomectomy (removal of the fibroids from the wall of the womb) and hysterectomy (removal of the womb). Non-surgical procedures include uterine artery embolisation (UAE), which involves blocking the blood vessels that supply the fibroids, causing them to shrink. The aim of this study is to compare UAE with surgery (hysterectomy and myomectomy) in patients with fibroids who would ordinarily receive surgical treatment.

Who can participate?
Women with symptomatic fibroids who would normally undergo surgery for treatment.

What does the study involve?
Participants are randomly allocated to be treated with either UAE or surgery. Their quality of life is assessed 12 months later.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Gartnavel General Hospital (UK)

When is the study starting and how long is it expected to run for?
November 2000 to September 2010

Who is funding the study?
Chief Scientist Office (UK)

Who is the main contact?
Prof. Jonathan Moss
jon.moss@northglasgow.scot.nhs.uk

Contact information

Prof Jonathan Moss
Scientific

Department of Radiology
Gartnavel General Hospital
1053 Great Western Road
Glasgow
G12 OYN
United Kingdom

Phone +44 (0)141 211 3115
Email jon.moss@northglasgow.scot.nhs.uk

Study information

Study designOpen randomised controlled trial allocation 2:1 in favour of new intervention
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleMulticentre randomised controlled trial comparing uterine artery embolisation with surgical treatment for uterine fibroids
Study acronymREST
Study objectivesCompare results of embolisation with surgery for uterine fibroids.
Ethics approval(s)Multicentre Reseach Ethics Committee (MREC) of Edinburgh, 11/05/2000, ref: MREC/00/0/29
Health condition(s) or problem(s) studiedUterine fibroids
InterventionUterine artery embolisation versus surgical treatment
Intervention typeOther
Primary outcome measureThe 36-item Short Form health survey (SF-36) quality of life questionnaire.
Secondary outcome measures1. Symptom scores
2. Complications
3. Return to lifestyle events
4. Pain scores
5. Cost analysis
Overall study start date01/11/2000
Completion date01/09/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants200
Key inclusion criteriaWomen with symptomatic fibroid who would normally undergo surgery for treatment.
Key exclusion criteria1. Pregnancy
2. Unable to image with magnetic resonance imaging (MRI)
3. Fibroid size less than 2 cm
4. Subserosal fibroid on a stalk
Date of first enrolment01/11/2000
Date of final enrolment01/09/2010

Locations

Countries of recruitment

  • United Kingdom

Study participating centre

Gartnavel General Hospital
Glasgow
G12 OYN
United Kingdom

Sponsor information

Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)
Hospital/treatment centre

300 Balgray Hill Road
Glasgow
G21 3UR
Scotland
United Kingdom

Phone +44 (0)141 211 1817
Email judith.godden@northglasgow.scot.nhs.uk
Website http://www.ngt.org
ROR logo "ROR" https://ror.org/05kdz4d87

Funders

Funder type

Government

Chief Scientist Office (UK) (ref: CZH/4/1)
Government organisation / Local government
Alternative name(s)
CSO
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 25/01/2007 Yes No
Results article results 01/07/2010 Yes No
Results article 5-year results 01/07/2011 Yes No

Editorial Notes

04/02/2016: Plain English summary added.